Sensoriis, Inc. develops innovative contact and non-contact sensor platforms for research and clinical applications. An experienced team of scientists, engineers, and clinicians implement the research and development endeavor on several fronts at Sensoriis. The business development and commercialization strategy of the company has been developed to address niche applications in, for example, zebrafish model sensors for laboratory research; mobile linked sensors for non-invasive fetal ECG and fetal heart rate monitoring; and sensors for the assessment of the progression of labor. Several patent applications have been filed covering some of the innovations. For disclosure, the devices being developed by Sensoriis are work in progress, and currently do not have FDA approval for clinical use in the US. The company is privately held, guided by a physician-scientist serial entrepreneur who has co-founded eleven medical device and technology companies, both in the US and Europe. Several of those companies are venture funded, and in various stages of commercialization.